Biblio Discovery — Demo Discovery Service

6 hasil untuk "Cohn, Erica"

Menampilkan 1–6 · 1,22 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Efficacy and Safety of Medical Interventions for Moderate to Severe Hidradenitis Suppurativa

    Garg, Amit; Cohn, Erica; Midgette, Bria dkk.

    JAMA Dermatol · 2025 · Inggris · PubMed Central

    IMPORTANCE: There is limited comparative information on regulatory approved and pipeline treatments in hidradenitis suppurativa (HS). OBJECTIVE: To compare efficacy, safety, and tolerability of treatments for moderate to severe HS. DATA SOURCES: MEDLINE, Embase, ClinicalTrials.gov, and Cochrane…

  2. Artikel Jurnal Teks lengkap

    Spine Pain and Metastatic Prostate Cancer: Defining the Contribution of Nonmalignant Etiologies

    Ruppert, Lisa Marie; Cohn, Erica Dayan; Keegan, Niamh M. dkk.

    JCO Oncol Pract · 2022 · Inggris · PubMed Central

    PURPOSE: In patients with metastatic prostate cancer (MPC), the contribution of nonmalignant etiologies to morbidity is often overlooked. METHODS: We retrospectively reviewed the documented specialist assessments of back pain in men with MPC in a joint medical oncology and physiatry clinic at our…

  3. Artikel Jurnal Teks lengkap

    Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer

    de Almeida, Daniel Vargas P.; Anderson, Justine M.; Danila, Daniel C. dkk.

    J Immunother Precis Oncol · 2023 · Inggris · PubMed Central

    INTRODUCTION: Use of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) during chemotherapy is associated with decreased hospitalization rates, improved quality of life, and longer survival. Limited data exist on the benefit of this symptom…

  4. Artikel Jurnal Teks lengkap

    Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)

    Morris, Michael J.; Mota, Jose Mauricio; Lacuna, Kristine dkk.

    Eur Urol Oncol · 2021 · Inggris · PubMed Central

    BACKGROUND: No standard of care exists for patients with high-risk biochemical recurrence (BCR) after prostatectomy. OBJECTIVE: To evaluate whether addition of docetaxel to androgen deprivation therapy (ADT) improved progression-free survival (PFS) in high-risk BCR patients. DESIGN, SETTING, AND…

  5. Artikel Jurnal Teks lengkap

    Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

    Autio, Karen A.; Antonarakis, Emmanuel S.; Mayer, Tina M. dkk.

    Eur Urol Open Sci · 2021 · Inggris · PubMed Central

    BACKGROUND: Phase 2 trial endpoints that can be utilized in high-risk biochemical recurrence (BCR) after prostatectomy as a way of more rapidly identifying treatments for phase 3 trials are urgently needed. The efficacy of abiraterone acetate plus prednisone (AAP) in BCR is unknown. OBJECTIVE: To…